1. Home
  2. TENX vs MYPS Comparison

TENX vs MYPS Comparison

Compare TENX & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$1.92

Market Cap

71.1M

Sector

Health Care

ML Signal

HOLD

Logo PLAYSTUDIOS Inc.

MYPS

PLAYSTUDIOS Inc.

HOLD

Current Price

$0.47

Market Cap

60.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
MYPS
Founded
1967
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
71.1M
60.3M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
TENX
MYPS
Price
$1.92
$0.47
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$29.67
$3.00
AVG Volume (30 Days)
4.7M
262.4K
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$235,097,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.40
52 Week High
$19.40
$1.08

Technical Indicators

Market Signals
Indicator
TENX
MYPS
Relative Strength Index (RSI) 27.98 34.27
Support Level $1.31 $0.47
Resistance Level $2.22 $0.54
Average True Range (ATR) 0.15 0.02
MACD 0.41 0.00
Stochastic Oscillator 43.87 21.16

Price Performance

Historical Comparison
TENX
MYPS

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Companies games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

Share on Social Networks: